One Acquisition Solution for Integrated Services Plus (OASIS+) Historically Underutilized Business Zone (HUBZone) Small Business Set-Aside Continuously Open Solicitation
Plain-English Summary
The General Services Administration is looking for one acquisition solution for integrated services plus (oasis+) historically underutilized business zone (hubzone) small business set-aside continuously open solicitation. This is a hubzone set aside contract, meaning only qualifying small businesses can bid. Responses are due in 184 days (January 11, 2027).
Contract Details
- Solicitation #
- 47QRCA23R0003-P2
- Type
- Solicitation
- NAICS Code
- 541990
- PSC Code
- R499
- Posted
- July 8, 2026
- Response Deadline
- January 11, 2027
Agency & Contact
- Department
- GENERAL SERVICES ADMINISTRATION
- Sub-agency
- FEDERAL ACQUISITION SERVICE
- Office
- GSA/FAS/PSHC/OASIS PLUS
- Point of Contact
- Senior Contracting Officer
- oasisplusopen@gsa.gov
- Senior Contracting Officer
- oasisplusopen@gsa.gov
Who Should Bid
- Businesses classified under NAICS 541990
- HUBZone certified businesses
- Must be registered in SAM.gov with active status
- Must have relevant past performance or capability statement
Tips for Winning This Contract
- You have time to prepare a thorough response — use it for teaming arrangements or subcontracting
- Contact the contracting officer with questions BEFORE the deadline — they want to help qualified bidders
- Review the full solicitation documents on SAM.gov for detailed requirements
- Check if there's an industry day or Q&A session listed
Download attachments, full requirements, and submit your response on SAM.gov
Get alerts for similar contracts
We'll notify you when new NAICS 541990 opportunities are posted — free.
Similar Opportunities
MAARNG HRF Supported Collective Training Exercise (SCTE) Support Services
Engine Water Sample Testing for MH-65E aircraft
R--VA-DIV OF MGMT ATHRTY STPF FELLOWSHIP
Army Capabilities Integration and Development System (ACIDS) Analysts Sources Sought
Histopathology and antibody screening of Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic preclinical trial samples.